financetom
Business
financetom
/
Business
/
Catalent Fiscal Q4 Adjusted Earnings, Net Revenue Climb
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Catalent Fiscal Q4 Adjusted Earnings, Net Revenue Climb
Aug 29, 2024 5:32 AM

08:08 AM EDT, 08/29/2024 (MT Newswires) -- Catalent ( CTLT ) reported fiscal Q4 adjusted earnings Thursday of $0.65 per diluted share, up from $0.02 a year earlier.

Analysts polled by Capital IQ expected $0.56.

Net revenue for the quarter ended June 30 was $1.3 billion, up from $1.06 billion a year earlier.

Analysts polled by Capital IQ expected $1.24 billion.

Catalent ( CTLT ) shares were up 1.7% in recent premarket trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Robinhood Markets Launches Legend Desktop Platform in UK
Robinhood Markets Launches Legend Desktop Platform in UK
May 28, 2025
07:08 AM EDT, 05/28/2025 (MT Newswires) -- Robinhood Markets ( HOOD ) said it began to roll out Wednesday its Robinhood Legend browser-based desktop platform for active traders in the UK. The new platform, available to account holders for free, gives traders a personalized trading setup, the ability to trade from any of its screens, charting tools, and real-time data,...
Aritzia Inks Automatic Share Purchase Plan
Aritzia Inks Automatic Share Purchase Plan
May 28, 2025
07:07 AM EDT, 05/28/2025 (MT Newswires) -- Clothing company Aritzia ( ATZAF ) overnight Tuesday said it signed an automatic share purchase plan with its designated broker as part of its previously announced normal course issuer bid (NCIB) to purchase up to around 4.2 million of its subordinate voting shares during the twelve-month period starting May 7. This plan will...
GSK, Spero to stop urinary tract infection drug trial due to early success
GSK, Spero to stop urinary tract infection drug trial due to early success
May 28, 2025
May 28 (Reuters) - Spero Therapeutics ( SPRO ) and partner GSK said on Wednesday that an experimental drug for complicated urinary tract infections met the main goal of a late-stage trial and the companies will be stopping the trial early for efficacy. (Reporting by Sriparna Roy in Bengaluru; Editing by Devika Syamnath) ...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved